TRRI

Healthcare Biotechnology

Alzex Neuropharma Inc.

$0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

602.107

Avg Volume

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/S Ratio

0.00

Margins

Gross Margin 9.1%

Operating Margin (6.7%)

Net Margin 0.7%

EBITDA Margin 0.2%

Growth & Returns

Revenue Growth (YoY)

23.6%

Return on Equity

2.8%

Return on Assets

(1.6%)

Liquidity & Leverage

Current Ratio

1.43

Quick Ratio

1.40

Debt / Equity

0.76

Total Cash

63,501

Total Debt

690,703

About

Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.